-
U.S. officials say vaccinated don't need booster right now
firstwordpharma
July 14, 2021
US health officials, following meeting with Pfizer, reiterated that Americans who have been fully vaccinated against COVID-19 do not need to get a booster shot at this time, as reported in the National Post.
-
PHE study finds COVID-19 vaccines ‘highly effective’ in at-risk groups
pharmatimes
July 13, 2021
A new study from Public Health England (PHE) has found COVID-19 vaccine are as effective at preventing symptomatic disease in most people in clinical risk groups as the rest of the population.
-
Pfizer to Meet With U.S. Officials About COVID-19 Booster Shot
drugs
July 13, 2021
Pfizer said it will meet with U.S. officials on Monday to discuss possible authorization for a third booster shot of its COVID-19 vaccine.
-
Big pharma collaborates on free resource linking genetic variants to human disease
europeanpharmaceuticalreview
July 12, 2021
The collaborative work has produced the largest browsable resource linking rare protein-coding genetic variants to human health and disease that will accelerate targeted drug development.
-
Israel offers Pfizer COVID-19 vaccine booster shots to adults at risk
firstwordpharma
July 12, 2021
Israel said on Sunday it will start offering a booster of Pfizer COVID-19 vaccine BNT162b2 to adults with impaired immune systems, but it was still considering whether a third round of shots should be given to the general public, as reported in Fidelity.
-
Pfizer, U.S. health officials to discuss COVID boosters on Monday
firstwordpharma
July 12, 2021
Pfizer said Sunday that it will meet with representatives of the FDA as soon as Monday to discuss the need for a booster dose of its COVID-19 vaccine as it prepares to seek authorization, as reported in Investing.com.
-
Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
firstwordpharma
July 09, 2021
Today, access to the world's largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie (NYSE: ABBV), Biogen Inc. (Nasdaq: BIIB) a
-
Pfizer plans to seek FDA nod for COVID-19 booster next month as Delta spreads
firstwordpharma
July 09, 2021
Pfizer's chief scientific officer Mikael Dolsten indicated Thursday that the company plans to seek an FDA emergency-use authorisation next month for a third dose of its COVID-19 vaccine BNT162b2.
-
U.S. to send 500,000 Pfizer COVID-19 vaccine doses to Uruguay
firstwordpharma
July 09, 2021
The United States will send 500,000 doses of Pfizer’s COVID-19 vaccine to Uruguay on Thursday, the White House said, as reported by the National Post.
-
Israel reports decrease in Pfizer vaccine effectiveness against infections
expresspharma
July 08, 2021
The decline coincided with the spread of the Delta variant and the end of social distancing restrictions in Israel.